Unicycive, which is seeking an FDA green light for oxylanthanum carbonate to treat hyperphosphatemia in patients with chronic kidney disease who are on dialysis, Monday said the agency set a target ...

activates fungal genes and proteins associated with phosphate metabolism, a system that is key to growth. This insight into how fungi respond to chemical signals at the molecular level could lead ...

Unicycive Therapeutics said the Food and Drug Administration accepted its application seeking approval of its lead drug candidate ... a condition involving too much phosphate in the blood that ...